You are here

Novartis

Biopharma buyouts bounce back

EP Vantage

Wed, 07/5/23 - 10:17 am

Horizon Therapeutics

Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis

Healio

Fri, 06/30/23 - 10:10 am

dry eye disease

Ex-Novartis NASH drug clears clinical test, fueling Boston's pursuit of Akero, 89bio

Fierce Biotech

Wed, 06/21/23 - 10:51 am

Boston Pharmaceuticals

Akero Therapeutics

CAR-T beyond cancer? Novartis and others say yes

EP Vantage

Mon, 06/19/23 - 10:19 am

Cartesian Therapeutics

Bristol Myers Squibb

Yake Biotechnology

Sandoz targets barriers to biosimilar accessibility with latest initiative

Pharmaceutical Technology

Thu, 06/15/23 - 07:00 pm

Biopharma Confronts a Rising Tide of Ransomware Attacks

BioSpace

Wed, 06/14/23 - 10:11 am

Hope springs for April inhibition

EP Vantage

Tue, 06/13/23 - 10:27 am

Chinook Therapeutics

April inhibition

Vera Therapeutics

Alpine Immune Sciences

Akso Biopharmaceutical

Aurinia Pharmaceuticals

Novartis to acquire kidney disease biotech Chinook for up to $3.5B

BioPharma Dive

Mon, 06/12/23 - 10:24 am

Chinook Therapeutics

EHA 2023 – Astrazeneca keeps up its complement defense

EP Vantage

Fri, 06/9/23 - 10:01 am

Novartis debuts hidradenitis suppurativa docuseries at Tribeca Film Festival

Medical Marketing and Media

Thu, 06/8/23 - 09:44 pm

hidradenitis suppurativa

pharma marketing

Sandoz hitches its wagon to biosimilars, predicting $3B in sales from pipeline products over next 5 years

Fierce Pharma

Thu, 06/8/23 - 09:29 pm

ASCO in Review: Oncologists See Practice-Changing, Affirming Data

BioSpace

Thu, 06/8/23 - 09:26 pm

non-small cell lung cancer

Moderna Therapeutics

After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints

Fierce Biotech

Wed, 06/7/23 - 10:15 am

Inflation Reduction Act

Novartis drug helps stop breast cancer’s return in large study

BioPharma Dive

Fri, 06/2/23 - 11:24 am

clinical trials

As Sandoz prepares to spin off from Novartis, the company sets sights on new crosstown headquarters

Fierce Pharma

Thu, 06/1/23 - 06:35 pm

Novartis buys priority review voucher from Pharming for discount price of $21M

Fierce Biotech

Thu, 06/1/23 - 11:40 am

priority review vouchers

ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers

Fierce Pharma

Thu, 05/25/23 - 08:33 pm

non-small cell lung cancer

early breast cancer

Novartis to buy Avrobio gene therapy for $88M, leaving rest of the biotech on the shelf

Fierce Biotech

Mon, 05/22/23 - 11:35 am

Novartis brings on 8 business vets for Sandoz's new board, including 4 women

Fierce Pharma

Tue, 05/16/23 - 12:12 pm

women executives

Pages